Vanguard Group’s Medtronic MDT Stock Holding History

Vanguard Group’s Portfolio MDT Stock Details MDT Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$11.1B	Buy	126,909,406 +1,895,165	+2%	+$165M	0.18%	96
2025 Q1	$11.2B	Buy	125,014,241 +810,854	+0.7%	+$72.9M	0.2%	85
2024 Q4	$9.92B	Buy	124,203,387 +754,395	+0.6%	+$60.3M	0.17%	96
2024 Q3	$11.1B	Sell	123,448,992 -3,158,079	-2%	-$284M	0.2%	83
2024 Q2	$9.97B	Buy	126,607,071 +323,738	+0.3%	+$25.5M	0.19%	90
2024 Q1	$11B	Sell	126,283,333 -264,723	-0.2%	-$23.1M	0.22%	75
2023 Q4	$10.4B	Buy	126,548,056 +438,864	+0.3%	+$36.2M	0.23%	72
2023 Q3	$9.88B	Buy	126,109,192 +267,821	+0.2%	+$21M	0.24%	66
2023 Q2	$11.1B	Buy	125,841,371 +206,692	+0.2%	+$18.2M	0.26%	63
2023 Q1	$10.1B	Buy	125,634,679 +507,977	+0.4%	+$41M	0.26%	67
2022 Q4	$9.72B	Buy	125,126,702 +1,264,708	+1%	+$98.3M	0.26%	68
2022 Q3	$10B	Buy	123,861,994 +1,056,995	+0.9%	+$85.4M	0.29%	56
2022 Q2	$11B	Buy	122,804,999 +2,247,511	+2%	+$202M	0.31%	55
2022 Q1	$13.4B	Buy	120,557,488 +7,403,778	+7%	+$821M	0.32%	54
2021 Q4	$11.7B	Buy	113,153,710 +654,088	+0.6%	+$67.7M	0.27%	60
2021 Q3	$14.1B	Buy	112,499,622 +720,332	+0.6%	+$90.3M	0.35%	48
2021 Q2	$13.9B	Buy	111,779,290 +717,126	+0.6%	+$89M	0.35%	48
2021 Q1	$13.1B	Sell	111,062,164 -223,854	-0.2%	-$26.4M	0.35%	46
2020 Q4	$13B	Sell	111,286,018 -589,565	-0.5%	-$69.1M	0.38%	47
2020 Q3	$11.6B	Sell	111,875,583 -1,237,067	-1%	-$129M	0.38%	49
2020 Q2	$10.4B	Sell	113,112,650 -4,622,375	-4%	-$424M	0.37%	49
2020 Q1	$10.6B	Buy	117,735,025 +3,117,546	+3%	+$281M	0.45%	39
2019 Q4	$13B	Buy	114,617,479 +1,106,561	+1%	+$126M	0.44%	36
2019 Q3	$12.3B	Buy	113,510,918 +1,176,633	+1%	+$128M	0.46%	35
2019 Q2	$10.9B	Buy	112,334,285 +640,083	+0.6%	+$62.3M	0.41%	37
2019 Q1	$10.2B	Sell	111,694,202 -288,974	-0.3%	-$26.3M	0.4%	39
2018 Q4	$10.2B	Buy	111,983,176 +2,535,489	+2%	+$231M	0.46%	34
2018 Q3	$10.8B	Buy	109,447,687 +1,199,118	+1%	+$118M	0.42%	37
2018 Q2	$9.27B	Buy	108,248,569 +1,279,249	+1%	+$110M	0.39%	41
2018 Q1	$8.58B	Buy	106,969,320 +43,572	+0%	+$3.5M	0.38%	43
2017 Q4	$8.63B	Buy	106,925,748 +1,438,726	+1%	+$116M	0.38%	43
2017 Q3	$8.2B	Buy	105,487,022 +710,986	+0.7%	+$55.3M	0.38%	42
2017 Q2	$9.3B	Buy	104,776,036 +2,454,380	+2%	+$218M	0.46%	35
2017 Q1	$8.24B	Buy	102,321,656 +4,412,536	+5%	+$355M	0.42%	36
2016 Q4	$6.97B	Buy	97,909,120 +1,010,412	+1%	+$72M	0.39%	40
2016 Q3	$8.37B	Buy	96,898,708 +1,221,005	+1%	+$105M	0.49%	31
2016 Q2	$8.3B	Buy	95,677,703 +1,489,823	+2%	+$129M	0.52%	31
2016 Q1	$7.06B	Buy	94,187,880 +4,448,206	+5%	+$334M	0.46%	37
2015 Q4	$6.9B	Buy	89,739,674 +2,935,600	+3%	+$226M	0.46%	37
2015 Q3	$5.81B	Buy	86,804,074 +463,528	+0.5%	+$31M	0.42%	40
2015 Q2	$6.4B	Buy	86,340,546 +863,771	+1%	+$64M	0.43%	42
2015 Q1	$6.67B	Buy	85,476,775 +27,156,460	+47%	+$2.12B	0.45%	38
2014 Q4	$4.21B	Buy	58,320,315 +1,649,756	+3%	+$119M	0.3%	53
2014 Q3	$3.51B	Buy	56,670,559 +142,435	+0.3%	+$8.82M	0.27%	62
2014 Q2	$3.6B	Buy	56,528,124 +637,061	+1%	+$40.6M	0.28%	59
2014 Q1	$3.44B	Buy	55,891,063 +933,209	+2%	+$57.4M	0.29%	57
2013 Q4	$3.15B	Buy	54,957,854 +980,556	+2%	+$56.3M	0.28%	63
2013 Q3	$2.87B	Buy	53,977,298 +551,848	+1%	+$29.4M	0.28%	64
2013 Q2	$2.75B	Buy	+53,425,450	New	+$2.75B	0.29%	62